[1] Duong T A. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases[J]. Clin Infect Dis, 1996, 23(1): 125-130.
[2] Piehl M R, Kaplan R L, Haber M H. Disseminated penicilliosis in a patient with acquired immunodeficiency syndrome[J]. Arch Pathol Lab Med, 1988, 112(12): 1262-1264.
[3] Vanittanakom N, Cooper C R, Jr., Fisher M C, Sirisanthana T. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects[J]. Clin Microbiol Rev, 2006, 19(1): 95-110.
[4] Le T, Wolbers M, Chi N H, Quang V M, Chinh N T, Lan N P, et al. Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet Nam[J]. Clin Infect Dis, 2011, 52(7): 945-952.
[5] Wu T C, Chan J W, Ng C K, Tsang D N, Lee M P, Li P C. Clinical presentations and outcomes of Penicillium marneffei infections: a series from 1994 to 2004[J]. Hong Kong Med J, 2008, 14(2): 103-109.
[6] Hu Y, Zhang J, Li X, Yang Y, Zhang Y, Ma J, et al. Penicillium marneffei infection: an emerging disease in mainland China[J]. Mycopathologia, 2013, 175(1-2): 57-67.
[7] Armstrong-James D, Meintjes G, Brown G D. A neglected epidemic: fungal infections in HIV/AIDS[J]. Trends Microbiol, 2014, 22(3): 120-127.
[8] Jiang J, Meng S, Huang S, Ruan Y, Lu X, Li J Z, et al. Effects of Talaromyces marneffei infection on mortality of HIV/AIDS patients in southern China: a retrospective cohort study[J]. Clin Microbiol Infect, 2019, 25(2): 233-241.
[9] Nor-Hayati S, Sahlawati M, Suresh-Kumar C, Lee K C. A retrospective review on successful management of Penicillium marneffei infections in patients with advanced HIV in Hospital Sungai Buloh[J]. Med J Malaysia, 2012, 67(1): 66-70.
[10] Liu B, Ping F U. Research Progress of Penicilliosis Marneffei[J]. Journal of Dermatology & Venereology, 2010.
[11] Wong S Y, Wong K F. Penicillium marneffei Infection in AIDS[J]. Patholog Res Int, 2011, 2011: 764293.
[12] Le T, Kinh N V, Cuc N T K, Tung N L N, Lam N T, Thuy P T T, et al. A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis[J]. N Engl J Med, 2017, 376(24): 2329-2340.
[13] Desakorn V, Smith M D, Walsh A L, Simpson A J, Sahassananda D, Rajanuwong A, et al. Diagnosis of Penicillium marneffei infection by quantitation of urinary antigen by using an enzyme immunoassay[J]. J Clin Microbiol, 1999, 37(1): 117-121.
[14] Chaiyaroj S C, Chawengkirttikul R, Sirisinha S, Watkins P, Srinoulprasert Y. Antigen detection assay for identification of Penicillium marneffei infection[J]. J Clin Microbiol, 2003, 41(1): 432-434.
[15] Kawila R, Chaiwarith R, Supparatpinyo K. Clinical and laboratory characteristics of penicilliosis marneffei among patients with and without HIV infection in Northern Thailand: a retrospective study[J]. BMC Infect Dis, 2013, 13: 464.
[16] Elias N A, Cuestas M L, Sandoval M, Poblete G, Lopez-Daneri G, Jewtuchowicz V, et al. Rapid identification of Histoplasma capsulatum directly from cultures by multiplex PCR[J]. Mycopathologia, 2012, 174(5-6): 451-456.
[17] Hien H T A, Thanh T T, Thu N T M, Nguyen A, Thanh N T, Lan N P H, et al. Development and evaluation of a real-time polymerase chain reaction assay for the rapid detection of Talaromyces marneffei MP1 gene in human plasma[J]. Mycoses, 2016, 59(12): 773-780.
[18] Pongpom M, Sirisanthana T, Vanittanakom N. Application of nested PCR to detect Penicillium marneffei in serum samples[J]. Med Mycol, 2009, 47(5): 549-553.
[19] Sun J, Najafzadeh M J, Zhang J, Vicente V A, Xi L, De Hoog G S. Molecular identification of Penicillium marneffei using rolling circle amplification[J]. Mycoses, 2011, 54(6): e751-759.
[20] Zhu Y M, Ai J W, Xu B, Cui P, Cheng Q, Wu H, et al. Rapid and precise diagnosis of disseminated T.marneffei infection assisted by high-throughput sequencing of multifarious specimens in a HIV-negative patient: a case report[J]. BMC Infect Dis, 2018, 18(1): 379.
[21] Prakit K, Nosanchuk J D, Pruksaphon K, Vanittanakom N, Youngchim S. A novel inhibition ELISA for the detection and monitoring of Penicillium marneffei antigen in human serum[J]. Eur J Clin Microbiol Infect Dis, 2016, 35(4): 647-656.
[22] Cao L, Chen D L, Lee C, Chan C M, Chan K M, Vanittanakom N, et al. Detection of specific antibodies to an antigenic mannoprotein for diagnosis of Penicillium marneffei penicilliosis[J]. J Clin Microbiol, 1998, 36(10): 3028-3031.
[23] Ning C, Lai J, Wei W, Zhou B, Huang J, Jiang J, et al. Accuracy of rapid diagnosis of Talaromyces marneffei: A systematic review and meta-analysis[J]. PLoS One, 2018, 13(4): e0195569.
[24] Rodriguez-Gallego E, Gomez J, Pacheco Y M, Peraire J, Vilades C, Beltran-Debon R, et al. A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients[J]. AIDS, 2018, 32(5): 565-573.
[25] Rodriguez-Gallego E, Gomez J, Domingo P, Ferrando-Martinez S, Peraire J, Vilades C, et al. Circulating metabolomic profile can predict dyslipidemia in HIV patients undergoing antiretroviral therapy[J]. Atherosclerosis, 2018, 273: 28-36.
[26] Konerman M A, Zhang Y, Zhu J, Higgins P D, Lok A S, Waljee A K. Improvement of predictive models of risk of disease progression in chronic hepatitis C by incorporating longitudinal data[J]. Hepatology, 2015, 61(6): 1832-1841.
[27] Wei R, Wang J, Wang X, Xie G, Wang Y, Zhang H, et al. Clinical prediction of HBV and HCV related hepatic fibrosis using machine learning[J]. EBioMedicine, 2018, 35: 124-132.
[28] Larsson M, Nguyen L H, Wertheim H F, Dao T T, Taylor W, Horby P, et al. Clinical characteristics and outcome of Penicillium marneffei infection among HIV-infected patients in northern Vietnam[J]. AIDS Res Ther, 2012, 9(1): 24.
[29] Cooper C R, Jr., Mcginnis M R. Pathology of Penicillium marneffei. An emerging acquired immunodeficiency syndrome-related pathogen[J]. Arch Pathol Lab Med, 1997, 121(8): 798-804.
[30] Hou J, Wang G, Wang F, Cheng J, Ren H, Zhuang H, et al. Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update)[J]. J Clin Transl Hepatol, 2017, 5(4): 297-318.
[31] Li W, Zhao J, Zou Z, Liu Y, Li B, Sun Y, et al. Analysis of hepatitis B virus intrahepatic covalently closed circular DNA and serum viral markers in treatment-naive patients with acute and chronic HBV infection[J]. PLoS One, 2014, 9(2): e89046.
[32] Yousukh A, Jutavijittum P, Pisetpongsa P, Chitapanarux T, Thongsawat S, Senba M, et al. Clinicopathologic study of hepatic Penicillium marneffei in Northern Thailand[J]. Arch Pathol Lab Med, 2004, 128(2): 191-194.